Responses
Scientific Abstracts
Oral Presentations
Abstract Session: Update on non anti-TNF biologics
OP0025 Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.